Over 20 Total Lots Up For Auction at One Location - TX Cleansweep 06/25

Patient iP and Clinerion enhance access to real world data for clinical trials

por John R. Fischer, Senior Reporter | September 10, 2018
European News Health IT
Clinerion and Patient iP are partnering to
accelerate clinical trial enrollment and
enhance the selection of clinical sites
Data solutions firm Clinerion has teamed up with health data and analytics enterprise Patient IP to provide greater access to real world data for the design and set up of clinical trials globally.

The two will utilize Clinerion’s patented Patient Network Explorer platform with Patient iP’s proprietary daTAscape solution to improve the selection of trial sites and accelerate patient enrollment.

“Our complementary technologies and global reach will now enable both Patient iP and Clinerion to view patient populations from a much more diverse and inclusive perspective than we are able to do independently of each other and thus, service our customers better than ever,” Michael Margiotta, chairman, founder and CEO of Patient iP, said in a statement.

Containing more than 16 million ambulatory EHRs across 5,000 practice sites, the cloud-based infrastructure of daTAscape enables it to aggregate patient data to streamline and accelerate the design, site selection and participant matching of clinical trials throughout the U.S., bring new therapies to the market faster and at more affordable rates.

Combined with the Patient Network Explorer platform, the solution will provide its users access to such information from Clinerion’s global network of partner hospitals, establishing a single comprehensive real-time view with an international footprint.

Features offered by the network include data-driven protocol optimization, site feasibility evaluation and patient search and identification, and the generation of real-world evidence for medical access. Big data analytics technologies used by Clinerion leverage real-time data from EHRs, which remain under the complete control of the network's participating hospitals, and comply with international patient privacy and data security regulations.

“The creation of a network of Clinerion alliance partners establishes a new, global and comprehensive, service resource for actionable patient data insights for clinical research,” Ian Rentsch, CEO of Clinerion, said in a statement. “We are happy to bring the international footprint of our hospital network to the benefit of Patient iP’s clients. At the same time, this collaboration will broaden our current ability to service clients with real-world data from the U.S. Our offerings complement each other well.”

Clinerion’s network consists of more than 17 million real-time patient lives, with an additional 55 million contracted and in implementation, across more than 100 providers throughout the Americas, Europe and Asia.

Back to HCB News

You Must Be Logged In To Post A Comment